AngioDynamics, The PERT Consortium™ Launch APEX-AV Study Assessing AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE System in Treatment of Pulmonary Embolism
AngioDynamics announced the launch of the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV), a new clinical study aimed at evaluating the efficacy and safety of their AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System in the treatment of acute intermediate-risk pulmonary embolism (PE).
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
Lead with Confidence. Attack with Control.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
NanoKnife 3.0 System
Your Treatment. Reimagined.
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Introducing the Next Generation of Peripheral Atherectomy Technology
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
Our Culture is Our Success
Become a proud member of our team
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.